Black Rock Inc. Lyell Immunopharma, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 13,495,132 shares of LYEL stock, worth $8.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,495,132

Previous 13,892,627 2.86%

Holding current value

$8.37 Million

Previous $31 Million 36.84%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.3 - $3.01 $516,743 - $1.2 Million	-397,495 Reduced 2.86%	13,495,132 $19.6 Million
Q1 2024 May 10, 2024	SELL	$1.71 - $3.07 $700,404 - $1.26 Million	-409,593 Reduced 2.86%	13,892,627 $31 Million
Q4 2023 Feb 13, 2024	BUY	$1.39 - $2.35 $1.23 Million - $2.07 Million	881,978 Added 6.57%	14,302,220 $27.7 Million
Q3 2023 Nov 13, 2023	BUY	$1.45 - $3.35 $490,751 - $1.13 Million	338,449 Added 2.59%	13,420,242 $19.7 Million
Q2 2023 Aug 11, 2023	BUY	$1.89 - $3.86 $1.41 Million - $2.87 Million	744,660 Added 6.04%	13,081,793 $41.6 Million
Q1 2023 May 12, 2023	BUY	$1.97 - $3.58 $331,194 - $601,866	168,119 Added 1.38%	12,337,133 $29.1 Million
Q4 2022 Feb 13, 2023	BUY	$2.78 - $8.09 $1.23 Million - $3.58 Million	441,912 Added 3.77%	12,169,014 $42.2 Million
Q3 2022 Nov 14, 2022	BUY	$5.54 - $8.27 $9.57 Million - $14.3 Million	1,727,389 Added 17.27%	11,727,102 $86 Million
Q2 2022 Aug 12, 2022	BUY	$3.68 - $6.8 $8.06 Million - $14.9 Million	2,190,223 Added 28.05%	9,999,713 $65.2 Million
Q1 2022 May 12, 2022	BUY	$5.05 - $7.7 $29.3 Million - $44.7 Million	5,810,038 Added 290.58%	7,809,490 $39.4 Million
Q4 2021 Feb 10, 2022	BUY	$7.13 - $15.19 $4.08 Million - $8.7 Million	572,555 Added 40.13%	1,999,452 $15.5 Million
Q3 2021 Nov 09, 2021	BUY	$11.0 - $17.95 $13 Million - $21.2 Million	1,179,288 Added 476.27%	1,426,897 $21.1 Million
Q2 2021 Aug 11, 2021	BUY	$15.99 - $16.89 $3.96 Million - $4.18 Million	247,609 New	247,609 $4.02 Million

Others Institutions Holding LYEL

# of Institutions

121

Shares Held

142M

Call Options Held

18.1K

Put Options Held

200

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $154M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account